Jo Ellen Frawley
Nurse Practitioner · Prairie du Sac, WINPI 1184625816
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $139,608 of the $193,586 with a category attached, or 72.1%. Novo Nordisk accounts for 61.4% of it on its own, with 9 other manufacturers making up the rest. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 417 payments — averaging $464.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$119K
- Lilly USA, LLC$34K
- Dexcom, Inc.$20K
- Abbott$18K
- AstraZeneca$3K
- Medtronic$47
- plus $59 from 4 others
What the payments were for
- Consulting fees$22,81612%
- Speaking & faculty fees$139,60872%
- Travel & lodging$21,45411%
- Food & beverage$9,5355%
- Education$1740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 205 | $118,949 |
| Lilly USA, LLC | 98 | $34,019 |
| Dexcom, Inc. | 42 | $19,590 |
| Abbott | 53 | $18,057 |
| AstraZeneca | 12 | $2,865 |
| Medtronic | 3 | $47 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
| Zealand Pharma US, Inc. | 1 | $13 |
| Insulet Corporation | 1 | $12 |
| Mannkind Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$50,820
- RYBELSUS$42,268
- MOUNJARO$31,705
- DEXCOM G7 GSS (161)$18,644
- FREESTYLE LIBRE 3$17,141
- DEXCOM STELO GLUCOSE BIOSENSOR$4,565
- FARXIGA$2,750
How this compares
$193,586 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 376 | $405,970 |
| Tresiba Flextouch U-200Insulin Degludec | 167 | $157,928 |
| MounjaroTirzepatide | 98 | $116,611 |
| TrulicityDulaglutide | 67 | $70,379 |
| Tresiba Flextouch U-100Insulin Degludec | 99 | $67,138 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 39 | $58,364 |
| JardianceEmpagliflozin | 64 | $51,350 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 54 | $46,098 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 36 | $40,189 |
| FarxigaDapagliflozin Propanediol | 42 | $37,408 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $23,951 |
| RybelsusSemaglutide | 17 | $22,764 |
| Victoza 3-PakLiraglutide | 14 | $12,624 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 12 | $10,223 |
| Humalog Kwikpen U-100Insulin Lispro | 47 | $8,650 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Xultophy 100-3.6, Rybelsus, Novolog | $118,949 | $493,358456 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $34,019 | $190,899185 claims |
| AstraZenecaFarxiga | $2,865 | $37,40842 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Other nurse practitioner in Prairie du Sac
- Kari FisherPrairie du Sac$57K
- Jodi StrongStevens Point$246K
- Trisha WilcoxMilwaukee$174K
- Sally BowaGreen Bay$117K
- Christina SauldMilwaukee$111K
- Melissa WendellWausau$98K
- Nicole BarteltWaukesha$85K
- Roxanne RadichAppleton$54K
- Kelly FlugaurMilwaukee$38K
- Christa ScheunemannWest Bend$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.